The matched placebo was identical to N -acetylcysteine in shape, color, size, and packaging but did not contain any active ingredients
About this article Cite this article Puche, J.E., Castilla-Cortzar, I
Can Res 67(15):73587367 Griffioen AW, Molema G (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation
Because peptides work with your bodys existing pathways rather than overriding them, they tend to act in a precise, focused way
The SURMOUNT-1 trial protocol allowed one dose de-escalation for intolerable side effects, which underscores that slower titration is acceptable and sometimes preferred